Zuckerberg-Backed Biohub Unveils Breakthrough in Inflammation Monitoring
The Chan Zuckerberg Biohub Chicago, supported by Mark Zuckerberg and Dr. Priscilla Chan, has published its first research on real-time inflammation monitoring using under-skin sensors. Conducted by Northwestern University researchers, the study, published in Science, involved diabetic rats and aims to provide continuous inflammation tracking, potentially allowing earlier intervention in inflammation-related diseases. The biohub, part of a $250 million initiative, collaborates with Illinois universities and focuses on inflammation research.